Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Hyperion Partners LLC

Hyperion Partners LLC raised its holdings in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 4.2% in the 1st quarter, HoldingsChannel.com reports. The fund owned 4,669 shares of the medical research company’s stock after buying an additional 187 shares during the quarter. Agilent Technologies comprises approximately 0.5% of Hyperion Partners LLC’s holdings, making the stock its 25th largest holding. Hyperion Partners LLC’s holdings in Agilent Technologies were worth $679,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the company. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in Agilent Technologies by 3.2% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 2,421 shares of the medical research company’s stock worth $337,000 after acquiring an additional 75 shares in the last quarter. Carmel Capital Partners LLC increased its holdings in Agilent Technologies by 1.2% in the 4th quarter. Carmel Capital Partners LLC now owns 6,709 shares of the medical research company’s stock worth $933,000 after acquiring an additional 78 shares in the last quarter. Monumental Financial Group Inc. increased its holdings in Agilent Technologies by 0.9% in the 4th quarter. Monumental Financial Group Inc. now owns 9,493 shares of the medical research company’s stock worth $1,320,000 after acquiring an additional 89 shares in the last quarter. Kepos Capital LP increased its holdings in Agilent Technologies by 3.5% in the 3rd quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock worth $310,000 after acquiring an additional 93 shares in the last quarter. Finally, Rosenberg Matthew Hamilton increased its holdings in Agilent Technologies by 51.1% in the 4th quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after acquiring an additional 96 shares in the last quarter.

Analysts Set New Price Targets

A has been the subject of several recent analyst reports. TD Cowen cut their price target on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating for the company in a report on Thursday, May 30th. Evercore ISI dropped their target price on shares of Agilent Technologies from $145.00 to $126.00 and set an “in-line” rating for the company in a report on Thursday, May 30th. Bank of America reaffirmed a “neutral” rating and set a $134.00 target price (down previously from $145.00) on shares of Agilent Technologies in a report on Thursday, May 30th. Stifel Nicolaus dropped their target price on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a report on Thursday, May 30th. Finally, Barclays dropped their target price on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating for the company in a report on Friday, May 31st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $136.50.

Get Our Latest Report on A

Insider Buying and Selling at Agilent Technologies

In other news, SVP Philip Binns sold 2,827 shares of the stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $147.54, for a total transaction of $417,095.58. Following the sale, the senior vice president now owns 9,997 shares of the company’s stock, valued at $1,474,957.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the transaction, the senior vice president now directly owns 49,486 shares in the company, valued at $6,595,494.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Philip Binns sold 2,827 shares of the stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $147.54, for a total transaction of $417,095.58. Following the completion of the transaction, the senior vice president now owns 9,997 shares in the company, valued at $1,474,957.38. The disclosure for this sale can be found here. Insiders have sold 19,785 shares of company stock valued at $2,670,836 over the last 90 days.

Agilent Technologies Trading Up 0.4 %

Shares of A stock traded up $0.52 on Friday, hitting $133.25. 4,461,292 shares of the stock traded hands, compared to its average volume of 2,344,093. The firm’s 50-day moving average price is $139.83 and its two-hundred day moving average price is $138.32. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. The stock has a market capitalization of $38.88 billion, a PE ratio of 31.50, a PEG ratio of 4.50 and a beta of 1.07.

Agilent Technologies (NYSE:AGet Free Report) last posted its earnings results on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.03. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The company had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the prior year, the company posted $1.27 earnings per share. Agilent Technologies’s revenue for the quarter was down 8.4% compared to the same quarter last year. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.25 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be given a $0.236 dividend. The ex-dividend date is Tuesday, July 2nd. This represents a $0.94 dividend on an annualized basis and a yield of 0.71%. Agilent Technologies’s payout ratio is currently 22.22%.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Read More

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.